Till startsida
To content Read more about how we use cookies on gu.se


Wallenberg Centre of Molecular and Translational Medicine is a new center at the University of Gothenburg. The center is being built in cooperation with Region Västra Götaland and AstraZeneca. Close interaction between the partners is important to ensure that the results of basic research quickly lead to new therapies and ensures patients get the benefit.

Over ten new careers positions for young researchers will be added at the University of Gothenburg. The researchers will get very good conditions and will add to the successful research that already exists at the University of Gothenburg, AstraZeneca and Sahlgrenska University Hospital.

The investment covers SEK 620 million over a ten year period. The Wallenberg Foundation has previously decided to contribute 270 million, Västra Götaland 150 million, Astra Zeneca will contribute with time and resources comprising 40 million for the first four years (with a possible extension thereafter), while the University of Gothenburg enters 160 million.


  • Göran Landberg, PhD, MD, professor at Sahlgrenska Cancer Centre (goran.landberg@gu.se)
    Director of Wallenberg Centre for Molecular and Translational Medicine
  • Julia Grönros, PhD (julia.gronros@gu.se)
    Research coordinator at Wallenberg Centre and research advisor at Grants and Innovation Office, University of Gothenburg
  • Tinna Carlsson - economist 
  • Lena Karlsson - HR officer 
  • Mattias Lindgren - communications officer
  • Louise Nilsson, PhD
    Project manager at Wallenberg Centre and Sahlgrenska Biobank/Gothia Forum

Find more information under Research Groups

Steering Committee

  • Eva Wiberg, vice-chancellor (chair)
  • Staffan Edén, deputy vice-chancellor
  • Eric Hanse, acting dean, Sahgrenska Academy
  • Richard Neutze, vice-director Inst. Cell & Mol.biology, Faculty of Science
  • Lars Grip, director research, development and eduction, Sahlgrenska University Hospital
  • Outi Vaarala, Head of Translational Biology, Respiratory Inflammation and Autoimmunity, AstraZeneca
  • Jan Holmgren, repr. Knut and Alice Wallenberg Foundation (co-opted member)
  • Göran Landberg, Director WCMTM (co-opted member)

Scientific Advisory Board

  • Professor Clare Isacke, Professor of Molecular Cell Biology, Breast Cancer Now Research Centre, Institute of Cancer Research, London, UK
  • Professor Iain Robinson, Professor of Neuroscience, Molecular Neuroendocrinology, National Institute for Medical Research, London, UK
  • Professor David Carling, Professor of Biochemistry, Institute of Clinical Science, Faculty of Medicine, Imperial College London, UK 

Grants and Innovation Office

The office function for Wallenberg Centre is placed at the Grants and Innovation Office, where over 30 experts in utilization, research and business law support the researchers and staff at University of Gothenburg.


Wallenberg Centres and SciLifeLab initiates Fellows Program

Read more in the press release from 28 of June.

Västra Götalandsregionen - Crowd Ideas

Citizens ideas become reality in health care - new ways to influence

Four Centres

The Wallenberg Centres for Molecular Medicine initiative is a joint venture with the Universities and University Hospitals of Gothenburg, Lund, Umeå and Linköping.

Read more at wcmm.se


WCMM Umeå inauguration


Director Retreat in Lund, April 2017
One part of the collaboration between the four Centres is yearly conferences. The first meeting was arranged by the team in Lund and included a visit to MAX IV  www.maxiv.lu.se/.

Knut and Alice Wallenberg Foundation

The Wallenberg Centre for Molecular and Translational Medicine is supported by Knut and Alice Wallenberg Foundation.

Page Manager: Pontus Sundén|Last update: 9/11/2017

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?